Recent advances in primary biliary cholangitis (PBC) care have resulted in a new focus on personalized care and symptom management. Tune in to learn from patient advocate, Maria G. Morais, RN, how you can integrate patient insights and priorities into treatment plans for PBC. Topics covered include:

• The Canadian PBC Society Survey: Comorbidities and Treatment Goals
• Defining and Achieving Goal-Driven Care for PBC 
• Recent Advances in PBC Management
• Newer Agents for Second-line Treatment of PBC

Presenters:

Maria G. Morais, RN
PBC Transplant Patient
VP Patient Advocacy
Canadian PBC Society
Toronto, Canada

Link to full program:
https://bit.ly/44ySoL3

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. 

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Tune in to listen as expert faculty, Dr Christopher L. Bowlus and Dr Sonal Kumar, discuss recent developments in treating primary biliary cholangitis (PBC) with new and emerging agents, as well as strategies to integrate these advances into clinical practice.

Topics covered include: 

• Methods of Assessing PBC Disease Progression
• Newer Agents for Second-line Treatment of PBC
• Prioritizing Symptom Management and Quality of Life With PBC Treatment

Presenters:

Christopher L. Bowlus, MD
Lena Valenta Professor and Chief
Division of Gastroenterology and Hepatology
School of Medicine 
University of California Davis 
Sacramento, California

Sonal Kumar, MD, MPH
Assistant Professor of Medicine
Division of Gastroenterology and Hepatology
Weill Cornell Medical College
New York, New York

Link to full program: 
https://bit.ly/43nHx6U

Get access to all of our new podcasts by subscribing to the CCO Medical Specialties Podcast on Apple Podcasts, Google Podcasts, or Spotify.  

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen as pulmonologist Peter Dicpinigaitis discusses his approach to the diagnosis and management of patients with refractory chronic cough in the context of a clinically relevant case and provides insights regarding emerging therapies.

Presenter
Peter Dicpinigaitis, MD
Professor of Medicine
Albert Einstein College of Medicine
Division of Critical Care Medicine
Montefiore Medical Center
Director, Montefiore Cough Center
Bronx, New York

Link to full program:
https://bit.ly/4kweynG

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen as Michael S. Benninger, MD, describes his approach to the diagnosis and management of chronic cough and refractory chronic cough in the context of a clinically relevant case.

Presenter
Michael S. Benninger, MD
Professor of Otolaryngology-Head and Neck Surgery
Lerner College of Medicine
The Cleveland Clinic
President, International Association of Phonosurgery
Cleveland, Ohio

Link to full program:
https://bit.ly/4kweynG

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen in as Joseph Kim, MD, MPH, MBA, and Colten Bracken, MD, FAAFP, discuss how to integrate comprehensive diabetes management to improve the quality of their obesity care delivery, including: 

• Documenting obesity as a diagnosis for patients with diabetes when appropriate
• Streamlining processes to ensure patients return for follow-up
• Dedicating a care manager to initiate patient outreach
• Implementing pharmacotherapy strategies to help patients control their A1C and achieve weight loss simultaneously.

Presenters

Joseph Kim, MD, MPH, MBA
President
Q Synthesis, LLC
Newtown, Pennsylvania

Colten Bracken, MD, FAAFP
Board of Directors for RHAU & UAFP
Owner/Medical Director
Main Street Family Medicine, PLLC
Enterprise, Utah

Link to full program: 
https://bit.ly/3IBFZi5

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Palak J. Trivedi, BSc, MBBS, PhD, MRCP, ESEGH​, discusses the most recent developments in primary biliary cholangitis (PBC) treatment, including cutting-edge data on new and emerging agents and how these updates may be integrated into your practice. Topics include:

• Steatotic liver disease and PBC
• Vibration-controlled transient elastography (VCTE) and discordant biochemical responses in PBC
• PPAR agonists and IBATs for PBC treatment

Presenter:

Palak J. Trivedi, BSc, MBBS, PhD, MRCP, ESEGH
Associate Professor
NIHR Birmingham BRC
University of Birmingham
Consultant Hepatologist, Liver Unit
University Hospitals Birmingham
Birmingham, United Kingdom

Link to full program: 
https://bit.ly/44ySoL3

Follow along with the slides: 
https://bit.ly/3IvwQrj

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify

.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Daniel C. Butler, MD, and Shawn G. Kwatra, MD, discuss the practical considerations for using IL-13 inhibitors to treat patients with moderate to severe atopic dermatitis, including:

• Patient candidacy considerations
• Treatment advancement strategies that go beyond topical therapies
• The importance of patient-centered care that address patients’ fears and needs
• A detailed patient case to highlight take home points

Presenter

Daniel C. Butler, MD​
Assistant Dean Student Affairs​
University of Arizona College of Medicine – Tucson​
Tucson, Arizona

Shawn G. Kwatra, MD​
Dr. Joseph W. Burnett Endowed Professor and Chair ​
Department of Dermatology​
University of Maryland School of Medicine​
Baltimore, Maryland

Program page:
https://bit.ly/4kTP04D

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Andrew F. Alexis, MD, MPH; Daniel C. Butler, MD; and Shawn G. Kwatra, MD, discuss IL-13 inhibition for treating patients with moderate to severe atopic dermatitis (AD), including:

• The available biologic therapies that specifically target IL-13
• Where these agents fall in the 2024 American Academy of Dermatology treatment algorithm
• How these agents compare to other AD therapies like topical corticosteroids and oral JAK inhibitors
• A detailed patient case to highlight take home points

Presenter

Andrew F. Alexis, MD, MPH​
Professor of Clinical Dermatology​
Weill Cornell Medical College ​
New York, New York

Daniel C. Butler, MD​
Assistant Dean Student Affairs​
University of Arizona College of Medicine – Tucson​
Tucson, Arizona

Shawn G. Kwatra, MD​
Dr. Joseph W. Burnett Endowed Professor and Chair ​
Department of Dermatology​
University of Maryland School of Medicine​
Baltimore, Maryland

Program page:
https://bit.ly/4kTP04D

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen in as Joseph Kim, MD, MPH, MBA; Manish Shah, MD; Martha Grugel, MA, discuss how they manage the prior authorization process for antiobesity agents to improve the quality of their care delivery, including:

• The information to collect during patient visits
• The available resources to help you submit prior authorizations
• The supporting documents that are often necessary to accompany prior authorizations
• How to address denials and appeals
• When to access manufacturer-based or foundation-based financial assistance

Presenters
Joseph Kim, MD, MPH, MBA
President
Q Synthesis, LLC
Newtown, Pennsylvania

Manish Shah, MD
Clinical Associate Faculty MS1 Preceptor
University of Florida College of Medicine
Gainesville, Florida

Martha Grugel, MA
Medical Assistant
Wesley Chapel, Florida

Link to full program: 
https://bit.ly/45P0v8z

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Andrew F. Alexis, MD, MPH, and Daniel C. Butler, MD, discuss the immunopathogenesis and role of IL-13 in atopic dermatitis (AD), including:

• Contributors to epidermal barrier dysfunction (eg, environmental triggers)
• IL-13 as a key cytokine in AD pathogenesis
• Targeted AD therapies that inhibit IL-13
• A detailed patient case to highlight take-home points

Presenter

Andrew F. Alexis, MD, MPH​
Professor of Clinical Dermatology​
Weill Cornell Medical College ​
New York, New York

Daniel C. Butler, MD​
Assistant Dean Student Affairs​
University of Arizona College of Medicine – Tucson​
Tucson, Arizona

Program page: 
https://bit.ly/4kTP04D

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.